US Pharma Faces Shortage of Lab Monkeys Amid China Export Curbs
The American pharmaceutical sector is struggling with a notable scarcity of monkeys used in laboratory research. Costs have climbed and import limits have worsened the problem, particularly after China restricted exports in 2020. Research labs have turned to suppliers in Cambodia, but this has raised ethical questions about where the animals come from. A startup backed by investor Joe Lonsdale intends to build a breeding facility to ease the supply shortfall.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.




Discussion (0)
Log in to join the discussion and vote.
Log in